Northern Trust
SIOX

Northern Trust’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Northern Trust’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-87,153
Closed -$37.9K – 4654
2022
Q4 		$37.9K Hold
87,153
– – ﹤0.01% 4350
2022
Q3 		$24K Hold
87,153
– – ﹤0.01% 4521
2022
Q2 		$31K Hold
87,153
– – ﹤0.01% 4550
2022
Q1 		$58K Hold
87,153
– – ﹤0.01% 4504
2021
Q4 		$112K Hold
87,153
– – ﹤0.01% 4387
2021
Q3 		$189K Sell
87,153
-34,510
-28% -$75K ﹤0.01% 4209
2021
Q2 		$333K Buy
+121,663
New +$302K ﹤0.01% 3888
2018
Q2 		– Sell
-41,792
Closed -$445K – 4340
2018
Q1 		$445K Sell
41,792
-93
-0.2% -$1.49K ﹤0.01% 3604
2017
Q4 		$1.77M Sell
41,885
-790
-2% -$35.4K ﹤0.01% 3209
2017
Q3 		$2.35M Buy
42,675
+2,339
+6% +$395K ﹤0.01% 3074
2017
Q2 		$7.48M Buy
40,336
+6,542
+19% +$1.15M ﹤0.01% 2354
2017
Q1 		$4.04M Buy
33,794
+4,923
+17% +$516K ﹤0.01% 2687
2016
Q4 		$2.87M Buy
28,871
+906
+3% +$95.4K ﹤0.01% 2890
2016
Q3 		$3.13M Buy
27,965
+10,591
+61% +$1.27M ﹤0.01% 2817
2016
Q2 		$1.78M Buy
17,374
+833
+5% +$83.3K ﹤0.01% 3105
2016
Q1 		$1.52M Buy
16,541
+49
+0.3% +$5.23K ﹤0.01% 3105
2015
Q4 		$2.38M Buy
16,492
+14,948
+968% +$1.95M ﹤0.01% 2958
2015
Q3 		$160K Buy
+1,544
New +$181K ﹤0.01% 3812

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Northern Trust's SIOX Position: Q1 2023 in Review

Northern Trust sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 87,153 shares — an estimated $37.9K sold.

Northern Trust first reported a position in SIOX in Q3 2015 and held it in 18 quarters. The position peaked at $7.48M in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Northern Trust reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 87,153 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $37.9K.
  • Northern Trust first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 18 quarters.
  • Northern Trust's Sio Gene Therapies Inc. Common Stock position peaked at $7.48M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.